The surging prevalence of foodborne zoonotic diseases in the U.S. is creating a huge requirement for animal healthcare products. Such diseases are caused by the intake of water or food contaminated by pathogenic microorganisms, such as viruses, parasites, and bacteria. These disease-causing microorganisms enter the animal body through the gastrointestinal tract, where the initial symptoms are observed. Most common foodborne zoonotic diseases are caused by listeria, salmonella, E. coli, campylobacter, yersinia, trichinella, cryptosporidium, toxoplasma, giardia, and toxins of Clostridium perfringens, Bacillus cereus, Staphylococcus aureus, and Clostridium botulinum, which can be eliminated by certain animal healthcare products.
Additionally, the increasing domestic consumption and export of meat and milk will support the U.S. animal healthcare market growth in the coming years. For instance, according to the U.S. Meat Export Federation (USMEF), between January 2021 and May 2021, the country exported 408,896 metric tons (mt), 325,747 mt, 174,280 mt, 92,437 mt, 81,203 mt, 57,723 mt, 59,604 mt, and 56,290 mt pork to China/Hong Kong, Mexico, Japan, Canada, South Korea, Central America, South America, and the Association of Southeast Asian Nation (ASEAN) members, respectively.
In recent years, companies operating in the U.S. animal healthcare market have been focusing on mergers and acquisitions and partnerships to capture a vast customer base. For example, in May 2018, Zoetis Inc. acquired Abaxis Inc., a veterinary point-of-care diagnostic instruments provider. Some of the other companies opting for such measures are Elanco Animal Health, C.H. Boehringer Sohn AG & Co. KG, Vetoquinol S.A, Bayer AG, HIPRA, Virbac Group, Huvepharma, Ceva Santé Animale, and Dechra Pharmaceuticals plc.
Thus, the rising prevalence of foodborne zoonotic diseases, surging domestic consumption and exports of milk and meat, and increasing adoption of companion animals will accelerate the consumption of animal healthcare products in the U.S. in the foreseeable future.